August 14, 2003 — When evaluating select patients with recurrent unexplained syncope, a diagnostic strategy of prolonged primary monitoring using an implantable loop recorder is more cost effective ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

May 10, 2005 (New Orleans) – Implantable loop recorders successfully provided a diagnosis in almost half of patients with unexplained syncope or presyncope, New York researchers reported at the Heart ...

Please provide your email address to receive an email when new articles are posted on . Continuous implantable loop recorder monitoring resulted in a threefold increase in atrial fibrillation ...

Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Implantable ...

DUBLIN--(BUSINESS WIRE)--The "Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac Centers and Other ...

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "North America Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, ...

SAN FRANCISCO, July 13, 2020 /PRNewswire/ -- The global implantable loop recorders market size is expected to reach USD 2.1 billion by 2027, expanding at a CAGR of 9.6%, according to a new report by ...